Perioperative beta-blocker therapy and mortality [3] (multiple letters)

New England Journal of Medicine

Volumn 353, Issue 23, 2005, Pages 2513-2515

  Vandenbunder, Benoit ^a   Mignon, Alexandre ^a   Dunn, Peter F ^b   Landesberg, Giora ^b   Tran, Henry A ^c   Tran, Paul H ^d   Lindenauer, Peter K ^e   Pekow, Penelope ^e   Benjamin, Evan M ^e  

^a Assistance Publique Hôpitaux de Paris ^*  (France)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INSULIN;

CLINICAL TRIAL; DRUG FATALITY; DRUG TOLERABILITY; HEART PROTECTION; HUMAN; LETTER; MAJOR SURGERY; MORTALITY; ORGAN INJURY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SIDE EFFECT; TISSUE OXYGENATION; CONGESTIVE HEART FAILURE; METHODOLOGY; NOTE; POSTOPERATIVE COMPLICATION; RISK; SURGERY; HEART INFARCTION; HYPERTENSION;

ADRENERGIC BETA-ANTAGONISTS; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RESEARCH DESIGN; RISK; SURGICAL PROCEDURES, OPERATIVE; HYPERTENSION; MYOCARDIAL INFARCTION;

EID: 28844506350     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM200512083532319     Document Type: Letter

References (0)